What are the inhaled drug delivery trends when designing dry powder devices for inhaled drugs? Andreas Meliniotis, Director of Device Development, answers the question in the latest issue of Contract Pharma Magazine; article entitled “Inhaled Drug Delivery Trends”.
When treating conditions that affect the lungs such as asthma or chronic obstructive pulmonary disease (COPD), inhaled delivery of drugs is often the most preferable choice, and there are a number of device platforms available to innovators. These include dry powder inhalers (DPIs), pressurized metered-dose inhalers (pMDIs) and nebulizers, but the decision as to which to use is dependent on a number of factors, and it is best to start from a “device agnostic” position, to avoid being swayed by previous projects or a technology bias towards a single platform.
For the full article “Inhaled Drug Delivery Trends”, click here.